SOFT TISSUE SARCOMA (STS)
Clinical trials for SOFT TISSUE SARCOMA (STS) explained in plain language.
Never miss a new study
Get alerted when new SOFT TISSUE SARCOMA (STS) trials appear
Sign up with your email to follow new studies for SOFT TISSUE SARCOMA (STS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced sarcoma: immunotherapy cocktail trial launches
Disease control Not yet recruitingThis study tests a new drug combination for people with advanced soft tissue sarcoma that has not responded to earlier treatments. The treatment includes an immunotherapy drug (epalrotokewali) plus chemotherapy and radiation. The goal is to see if this combination can shrink tumo…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New combo therapy aims to shrink sarcomas before surgery
Disease control Not yet recruitingThis study tests whether giving a short course of radiation together with immunotherapy before surgery can help people with a rare type of cancer called retroperitoneal sarcoma. About 28 adults whose tumors are hard to remove completely will receive this combination treatment. Th…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New combo therapy aims to control Hard-to-Treat sarcomas
Disease control Not yet recruitingThis phase 2 trial tests a new treatment for soft tissue sarcoma that combines a special type of radiation with an immunotherapy strategy called PraG (using Toripalimab, GM-CSF, and Thymalfasin). The goal is to see if this combination can shrink tumors or stop them from growing i…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: PHASE2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated May 16, 2026 23:37 UTC
-
Glow-in-the-Dark dye could help surgeons spot sarcoma
Knowledge-focused Not yet recruitingThis early-phase trial tests whether a fluorescent dye called 5-ALA can help surgeons see soft-tissue sarcoma tumors during surgery. The dye is given to patients a few hours before the operation and makes tumor tissue glow under a special light. The study will enroll 20 adults wi…
Matched conditions: SOFT TISSUE SARCOMA (STS)
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated May 16, 2026 23:50 UTC